These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 6752167

  • 1. Human prolactin-producing adenomas and bromocriptine: a histological, immunocytochemical, ultrastructural, and morphometric study.
    Tindall GT, Kovacs K, Horvath E, Thorner MO.
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1178-83. PubMed ID: 6752167
    [No Abstract] [Full Text] [Related]

  • 2. Pathology of prolactin cell adenomas of the human pituitary.
    Horvath E, Kovacs K.
    Semin Diagn Pathol; 1986 Feb; 3(1):4-17. PubMed ID: 3303229
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Medical treatment of prolactin-secreting pituitary adenomas. Influence of the size of the adenoma].
    Kuhn JM, Gancel A, Weinstein A, Courtois H, Schrub JC, Tadie M, Wolf LM.
    Presse Med; 1985 Mar 02; 14(9):525-8. PubMed ID: 3157164
    [Abstract] [Full Text] [Related]

  • 6. Bromocriptine treatment of macroprolactinomas: studies on the time course of tumor shrinkage and morphology.
    Nissim M, Ambrosi B, Bernasconi V, Giannattasio G, Giovanelli MA, Bassetti M, Vaccari U, Moriondo P, Spada A, Travaglini P, Faglia G.
    J Endocrinol Invest; 1982 Mar 02; 5(6):409-15. PubMed ID: 7169515
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Reduction in size of a pituitary tumor by bromocriptine therapy.
    McGregor AM, Scanlon MF, Hall K, Cook DB, Hall R.
    N Engl J Med; 1979 Feb 08; 300(6):291-3. PubMed ID: 759882
    [No Abstract] [Full Text] [Related]

  • 10. [Effect of postoperative bromocriptine treatment for prolactin-secreting pituitary adenomas].
    Sato O, Niwa J, Inoue Y, Akagawa S, Kobayashi K.
    No Shinkei Geka; 1983 Jan 08; 11(1):51-60. PubMed ID: 6682184
    [No Abstract] [Full Text] [Related]

  • 11. Antitumor effect of bromocriptine on estrogen-induced rat prolactinomas: ultrastructural alterations of secretory granules.
    Saitoh Y, Koizumi K, Arita N, Hayakawa T, Mogami H, Matsumoto K, Mori H.
    Anticancer Res; 1986 Jan 08; 6(5):1149-55. PubMed ID: 3800323
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Prolactin adenoma with ophthalmological manifestations. Treatment with bromocriptine].
    Saraux H, Offret H, Brasnu C, Charpentier G.
    Bull Soc Ophtalmol Fr; 1980 Jan 08; 80(6-7):489-93. PubMed ID: 7408092
    [No Abstract] [Full Text] [Related]

  • 18. Bromocriptine treatment of prolactinomas.
    von Werder K, Eversmann T, Fahlbusch R, Rjosk HK.
    N Engl J Med; 1979 Jun 14; 300(24):1391-2. PubMed ID: 440368
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Bromocriptine treatment of prolactinomas.
    Aronoff SL, Daughaday WH, Laws ER.
    N Engl J Med; 1979 Jun 14; 300(24):1391. PubMed ID: 440366
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.